SEARCH

SEARCH BY CITATION

References

  • 1
    Demetris AJ, Murase N, Lee RG, Randhawa P, Zeevi A, Pham S, Duquesnoy R, et al. Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts. Ann Transplant 1997; 2:2744.MEDLINE
  • 2
    Starzl TE, Todo S, Fung J, Demetris AJ, Venkataramman R, Jain A. FK 506 for liver, kidney, and pancreas transplantation. Lancet 1989; 2:10001004.MEDLINE
  • 3
    Demetris AJ, Fung JJ, Todo S, Banner B, Zerbe T, Sysyn G, Starzl TE. Pathologic observations in human allograft recipients treated with FK 506. Transplant Proc 1990; 22:2534.MEDLINE
  • 4
    Pirsch JD, Kalayoglu M, Hafez GR, D'Alessandro AM, Sollinger HW, Belzer FD. Evidence that the vanishing bile duct syndrome is vanishing. Transplantation 1990; 49:10151018.MEDLINE
  • 5
    Freese DK, Snover DC, Sharp HL, Gross CR, Savick SK, Payne WD. Chronic rejection after liver transplantation: a study of clinical, histopathologic and immunological features. Hepatology 1991; 13:882891.MEDLINE
  • 6
    Wiesner RH, Ludwig J, van Hoek B, Krom RA. Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failure. 4 Pt 1 Hepatology 1991; 14:721729.MEDLINE
  • 7
    Hubscher SG, Buckels JA, Elias E, McMaster P, Neuberger J. Vanishing bile-duct syndrome following liver transplantation—is it reversible? Transplantation 1991; 51:10041010.MEDLINE
  • 8
    Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance [Review]. Lancet 1992; 339:15791582.MEDLINE
  • 9
    Group EFMLS. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group. Lancet 1994; 344:423428.MEDLINE
  • 10
    Sher LS, Cosenza CA, Michel J, Makowka L, Miller CM, Schwartz ME, Busuttit R, et al. Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study Group. Transplantation 1997; 64:258263.MEDLINE
  • 11
    Blakolmer K, Seaberg EC, Batts K, Ferrell L, Markin R, Wiesner R, Detre K, et al. Analysis of the reversibility of chronic liver allograft rejection-implications for a staging schema. Am J Surg Pathol 1999; 23:13281339.MEDLINE
  • 12
    Quiroga J, Colina I, Demetris AJ, Starzl TE, Van Thiel DH. Cause and timing of first allograft failure in orthotopic liver transplantation: a study of 177 consecutive patients. Hepatology 1991; 14:10541062.MEDLINE
  • 13
    Backman L, Gibbs J, Levy M, McMillan R, Holman M, Husberg B, Goldstein R, et al. Causes of late graft loss after liver transplantation. Transplantation 1993; 55:10781082.MEDLINE
  • 14
    Pappo O, Ramos H, Starzl TE, Fung JJ, Demetris AJ. Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. Am J Surg Pathol 1995; 19:192206.MEDLINE
  • 15
    Slapak GI, Saxena R, Portmann B, Gane E, Devlin J, Calne R, Williams R. Graft and systemic disease in long-term survivors of liver transplantation. Hepatology 1997; 25:195202.MEDLINE
  • 16
    Porte RJ, Ploeg RJ, Hansen B, van Bockel JH, Thorogood J, Persijn GG, Hermans J, et al. Long-term graft survival after liver transplantation in the UW era: late effects of cold ischemia and primary dysfunction. European Multicentre Study Group. Transpl Int 1998; 11(Suppl 1):S164S167.MEDLINE
  • 17
    Mazariegos GV, Reyes J, Marino IR, Demetris AJ, Flynn B, Irish W, McMichael J, et al. Weaning of immunosuppression in liver transplant recipients. Transplantation 1997; 63:243249.MEDLINE
  • 18
    McKee M, Mattei P, Schwarz K, Wise B, Colombani P. Steroid withdrawal in tacrolimus (FK506)-treated pediatric liver transplant recipients. J Pediatr Surg 1997; 32:973975.MEDLINE
  • 19
    Gomez R, Moreno E, Colina F, Loinaz C, Gonzalez-Pinto I, Lumbreras C, Perez-Cerda F, et al. Steroid withdrawal is safe and beneficial in stable cyclosporine-treated liver transplant patients. J Hepatol 1998; 28:150156.MEDLINE
  • 20
    Devlin J, Doherty D, Thomson L, Wong T, Donaldson P, Portmann B, Williams R. Defining the outcome of immunosuppression withdrawal after liver transplantation. Hepatology 1998; 27:926933.MEDLINE
  • 21
    Banff schema for grading liver allograft rejection: an international consensus document. Anonymous. Hepatology 1997; 25:658663.MEDLINE
  • 22
    Wiesner RH, Demetris AJ, Belle SH, Seaberg EC, Lake JR, Zetterman RK, Everhart J, et al. Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome. Hepatology 1998; 28:638645.MEDLINE
  • 23
    Ormonde DG, de Boer WB, Kierath A, Bell R, Shilkin KB, House AK, Jeffery GP, et al. Banff schema for grading liver allograft rejection: utility in clinical practice. Liver Transpl Surg 1999; 5:261268.MEDLINE
  • 24
    Blakolmer K, Jain A, Ruppert K, Gray E, Duquesnoy R, Murase N, Starzl TE, et al. Chronic liver allograft rejection in a 1000+ Tacrolimus-treated cohort with a median follow-up of more than 5 years. Tansplantation 2000 (in press).
  • 25
    Wiesner R, Demetris A, Seaberg E. Chronic liver allograft rejection: clinical features and outcome (in preparation).
  • 26
    Neil D, Hubscher S. Histological changes during the evolution of chronic rejection of liver allografts (in preparation).
  • 27
    Gouw A. Early predictors and transitional features from acute to chronic liver allograft rejection (in preparation).
  • 28
    Hubscher SG. Studies of chronic hepatitis in the liver allograft. Is this a form of chronic rejection? (in preparation).
  • 29
    Nakazawa Y, Walker NSL, Clouston A. Venous sclerosis and fibrosis in chronic rejection of liver allografts. 2000 (submitted).
  • 30
    Lautenschlager I, Hockerstedt K, Jalanko H, Loginov R, Salmela K, Taskinin E, Ahonen J. Persistent cytomegalovirus in liver allografts with chronic rejection. Hepatology 1997; 25:190194.MEDLINE
  • 31
    Quaglia A, Del Vecchio Blanco G, Burroughs A, Dhillon A. Development of ductopaenic liver allograft rejection includes a “hepatitic” phase prior to duct loss. J Hepatol 1999; 30(Suppl 1):76.
  • 32
    Terminology for hepatic allograft rejection. International Working Party. Anonymous. Hepatology 1995; 22:648654.MEDLINE
  • 33
    Ludwig J, Wiesner RH, Batts KP, Perkins JD, Krom RA. The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation. Hepatology 1987; 7:476483.MEDLINE
  • 34
    Wiesner RH, Ludwig J, Van Hoek B, Krom RAF. Chronic hepatic allograft rejection: a review of ductopenic rejection and the vanishing bile duct syndrome. In: LCPaul, KSolez, eds. Organ Transplantation: Long-Term Results. New York: Marcel Dekker, 1992;197216.
  • 35
    Lowes J, Hubscher S, Neuberger J. Chronic rejection of the liver allograft. Gastroenterol Clin North Am 1993; 22:401420.MEDLINE
  • 36
    Fennell RH. Ductular damage in liver transplant rejection: its similarity to that of primary biliary cirrhosis and graft-versus-host disease. Pathol Annu 1981; 16:289294.MEDLINE
  • 37
    Grond J, Gouw ASH, Poppema S, Sloof MJH, Gips CH. Chronic rejection in liver transplants: a histopathologic analysis of failed grafts and antecedent serial biopsies. Transplant Proc 1986; 16:128135.
  • 38
    Oguma S, Belle S, Starzl TE, Demetris AJ. A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors. Hepatology 1989; 9:204209.MEDLINE
  • 39
    Wight DA. Chronic liver transplant rejection: definition and diagnosis. Transplant Proc 1996; 28:465467.MEDLINE
  • 40
    Vierling JM, Fennell RH. Histopathology of early and late human hepatic allograft rejection. Evidence of progressive destruction of interlobular bile ducts. Hepatology 1985; 5:10761082.MEDLINE
  • 41
    Portmann B, Neuberger J, Williams R. Intrahepatic bile duct lesions. In: RYCalne, ed. Liver Transplantation. the Cambridge-Kings College Hospital Experience. London: Grune & Stratton, 1983;279.
  • 42
    Neil DA, Adams DH, Gunson B, Hubscher SG. Is chronic rejection of liver transplants different from graft arteriosclerosis of kidney and heart transplants? Transplant Proc 1997; 29:25392540.MEDLINE
  • 43
    Demetris AJ, Seaberg EC, Batts KP, Ferrell L, Lee RG, Markin R, Detre K. Chronic liver allograft rejection: a National Institute of Diabetes and Digestive and Kidney Diseases interinstitutional study analyzing the reliability of current criteria and proposal of an expanded definition. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Am J Surg Pathol 1998; 22:2839.MEDLINE
  • 44
    Demetris AJ, Fung JJ, Todo S, McCauley J, Jain A, Takaya S, Alessiani M, et al. Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy—a clinicopathologic study of 96 patients. Transplantation 1992; 53:10561062.MEDLINE
  • 45
    Hubscher SG, Elias E, Buckels JA, Mayer AD, McMaster P, Neuberger JM. Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation. J Hepatol 1993; 18:173184.MEDLINE
  • 46
    White RM, Zajko AB, Demetris AJ, Bron KM, Dekker A, Starzl TE. Liver transplant rejection: angiographic findings in 35 patients. Am J Roentgenol 1987; 148:10951098.
  • 47
    Devlin J, Page AC, O'Grady J, Portmann B, Karani J, Williams R. Angiographically determined arteriopathy in liver graft dysfunction and survival. J Hepatol 1993; 18:6873.MEDLINE
  • 48
    Candinas D, Gunson BK, Nightingale P, Hubscher S, McMaster P, Neuberger JM. Sex mismatch as a risk factor for chronic rejection of liver allografts. Lancet 1995; 346:11171121.MEDLINE
  • 49
    Farges O, Nocci Kalil A, Sebagh M, Reynes M, Bismuth H. Low incidence of chronic rejection in patients experiencing histological acute rejection without simultaneous impairment in liver function tests. Transplant Proc 1995; 27:11421143.MEDLINE
  • 50
    Anand AC, Hubscher SG, Gunson BK, McMaster P, Neuberger JM. Timing, significance, and prognosis of late acute liver allograft rejection. Transplantation 1995; 60:10981103.MEDLINE
  • 51
    Devlin JJ, O'Grady JG, Tan KC, Calne RY, Williams R. Ethnic variations in patient and graft survival after liver transplantation. Identification of a new risk factor for chronic allograft rejection. Transplantation 1993; 56:13811384.MEDLINE
  • 52
    Batts KP, Moore SB, Perkins JD, Wiesner RH, Grambsch PM, Krom R. Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allografts. Transplantation 1988; 45:376379.MEDLINE
  • 53
    Donaldson PT, Alexander GJ, O'Grady J, Neuberger J, Portmann B, Thick M, Davis H, et al. Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation. Lancet 1987; 1:945951.MEDLINE
  • 54
    Donaldson P, Underhill J, Doherty D, Hayllar K, Calne R, Tan KC, O'Grady J, et al. Influence of human leukocyte antigen matching on liver allograft survival and rejection: “the dualistic effect.” Hepatology 1993; 17:10081015.MEDLINE
  • 55
    Donaldson PT, Thomson LJ, Heads A, Underhill JA, Vaughan RW, Rolando N, Williams R. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry. Transplantation 1995; 60:10161023.MEDLINE
  • 56
    Manez R, White LT, Linden P, Kusne S, Martin M, Kramer D, Demetris AJ, et al. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation. Transplantation 1993; 55:10671071.MEDLINE
  • 57
    Paya CV, Wiesner RH, Hermans PE, Larson-Keller JJ, Ilstrup DM, Krom R, Moore SB, et al. Lack of association between cytomegalovirus infection, HLA matching and the vanishing bile duct syndrome after liver transplantation. Hepatology 1992; 16:6670.MEDLINE
  • 58
    Halloran PF, Melk A, Barth C. Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J Am Soc Nephrol 1999; 10:167181.MEDLINE
  • 59
    Paul LC. Antibodies and chronic organ graft rejection. Ann Transplant 1997; 2:4652.MEDLINE
  • 60
    Tullius SG, Nieminen M, Qun Y, Egermann F, Reutzer-Selke A, Jonas S, Pratschke J, et al. Synergistic mechanisms of alloantigen-dependent and independent events in chronic graft rejection. Transplant Proc 1998; 30:24112412.MEDLINE
  • 61
    Deligeorgi-Politi H, Wight DG, Calne RY, White DG. Chronic rejection of liver transplants revisited [published erratum appears in Transpl Int 1995;8:163]. Transpl Int 1994; 7:442447.MEDLINE
  • 62
    Oguma S, Zerbe T, Banner B, Belle S, Starzl TE, Demetris AJ. Chronic liver allograft rejection and obliterative arteriopathy: possible pathogenic mechanisms. 1 Pt 2 Transplant Proc 1989; 21:22032207.MEDLINE
  • 63
    Matsumoto Y, McCaughan GW, Painter DM, Bishop GA. Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejection. Transplantation 1993; 56:6975.MEDLINE
  • 64
    Demetris AJ, Fung JJ, Todo S, McCauley J, Jain A, Takaya S, Alesianni M, et al. FK 506 used as rescue therapy for human liver allograft recipients. Transplant Proc 1991; 23:30053006.MEDLINE
  • 65
    Crawford AR, Lin XZ, Crawford JM. The normal adult human liver biopsy: a quantitative reference standard. Hepatology 1998; 28:323331.MEDLINE
  • 66
    Nakanuma Y, Ohta G. Histometric and serial section observations of the intrahepatic bile ducts in primary biliary cirrhosis. Gastroenterology 1979; 76:13261332.MEDLINE
  • 67
    Popper H, Kent G, Stein R. Ductular cell reaction in the liver in hepatic injury. J Mt Sinai Hosp 1957; 24:551556.
  • 68
    Popper H. The relation of mesenchymal cell products to hepatic epithelial systems [Review]. Prog Liver Dis 1990; 9:2738.MEDLINE
  • 69
    Burt AD, MacSween RN. Bile duct proliferation—its true significance? [Review]. Histopathology 1993; 23:599602.MEDLINE
  • 70
    Kemnitz J, Gubernatis G, Bunzendahl H, Ringe B, Pichlmayr R, Georgii A. Criteria for the histopathologic classification of liver allograft rejection and their clinical relevance. 1 Pt 2 Transplant Proc 1989; 21:22082210.MEDLINE
  • 71
    Demetris AJ, Murase N, Starzl TE, Fung JJ. Pathology of chronic rejection: an overview of common findings and observations about pathogenic mechanisms and possible prevention. Graft 1998; 1:5259.
  • 72
    Kemnitz J, Ringe B, Cohnert TR, Gubernatis G, Choritz H, Georgii A. Bile duct injury as a part of diagnostic criteria for liver allograft rejection. Hum Pathol 1989; 20:132143.MEDLINE